President Trump's executive order on drug pricing caused a surprising rally in pharmaceutical stocks. Read my analysis of PJP ...

ACADIA Pharmaceuticals has a rock solid balance sheet and advancing a couple of key drug candidates within its pipeline.

As the US government, under President Donald Trump, is on the verge of announcing significant new tariffs on pharmaceutical ...

On Monday, the shares of Murae Organisor joined the momentum of the pharmaceutical industry on D-Street. A 4% upper circuit ...

Kirkpatrick noted that the company continues to work on the development of its lead product, PF614, an extended-release oxycodone to treat severe pain, as well as its combination product, PF614-MPAR, ...

Corvus reported strong Phase 1 results for soquelitinib in atopic dermatitis, with early efficacy and no major safety concerns across all dose groups.

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands ...

Learn more about whether ACADIA Pharmaceuticals Inc. or BioCryst Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Alkermes plc or BioCryst Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Medicus to acquire Antev and expand into urology with Teverelix while reporting positive data in its Phase 2 skin cancer ...

Company reports $3.4 million in YCANTH revenue, reflective of increasing demand, following the dispensing of more than 10,000 applicator units in t ...

Q1 2025 Earnings Call Transcript May 8, 2025 Crinetics Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...